Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Leukemia | D007938 | — | C95 | 8 | 7 | 1 | — | — | 15 |
Myeloid leukemia acute | D015470 | — | C92.0 | 8 | 6 | 1 | — | — | 11 |
Myeloid leukemia | D007951 | — | C92 | 6 | 2 | 1 | — | — | 8 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Myelodysplastic syndromes | D009190 | — | D46 | 7 | 5 | — | — | — | 10 |
Preleukemia | D011289 | — | — | 5 | 4 | — | — | — | 8 |
Syndrome | D013577 | — | — | 5 | 4 | — | — | — | 8 |
Myeloproliferative disorders | D009196 | — | D47.1 | 4 | 1 | — | — | — | 4 |
Promyelocytic leukemia acute | D015473 | — | C92.4 | — | 2 | — | — | — | 2 |
Myelodysplastic-myeloproliferative diseases | D054437 | — | — | 2 | 1 | — | — | — | 2 |
Bcr-abl positive chronic myelogenous leukemia | D015464 | EFO_0000340 | — | 1 | 1 | — | — | — | 2 |
Neutropenia | D009503 | — | D70 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Myelomonocytic leukemia chronic | D015477 | — | C93.1 | 2 | — | — | — | — | 2 |
Myelomonocytic leukemia juvenile | D054429 | — | C93.3 | 2 | — | — | — | — | 2 |
Multiple myeloma | D009101 | — | C90.0 | 1 | — | — | — | — | 1 |
Plasma cell neoplasms | D054219 | — | — | 1 | — | — | — | — | 1 |
Anemia | D000740 | HP_0001903 | D64.9 | 1 | — | — | — | — | 1 |
Refractory anemia with excess of blasts | D000754 | — | D46.2 | 1 | — | — | — | — | 1 |
Refractory anemia | D000753 | — | — | 1 | — | — | — | — | 1 |
Drug common name | Lintuzumab |
INN | lintuzumab |
Description | Lintuzumab (humanized mab) |
Classification | Antibody |
Drug class | monoclonal antibodies |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL2109150 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | V00Y10W60W (ChemIDplus, GSRS) |